...raised $21.5 million in a series A round co-led by HealthCare Ventures; Morgenthaler Ventures; and Sequel Venture Partners...

...Boston Life Science Venture Corp.; and WRF Capital joined existing investors HealthCare Ventures; Morgenthaler Ventures; Sequel Venture Partners...

...round were Duquesne; Healthcare Investment Partners; MDS Capital; HealthCare Ventures; TPG Ventures; Morgenthaler Ventures; Perseus; Sequel Venture Partners...

...Genentech (DNA); Partners Healthcare; and GC&H Investments joined existing investors HealthCare Ventures; Morgenthaler Ventures; and Sequel Venture Partners...

...Healthcare Investment Partners; and MDS Capital. Existing investors HealthCare Ventures; TPG Ventures; Morgenthaler Ventures; Perseus; Sequel Venture Partners...

...at $6.53. Investors included existing stockholders New Enterprise Associates; InterWest Partners; Perseus-Soros Biopharmaceutical Fund; and Sequel Venture Partners...

...1.8 million shares at $7.80 each. Investors included New Enterprise Associates; InterWest Partners; Perseus-Soros; and Sequel Venture Partners...

...TPG Ventures led the round. Other investors included Perseus-Soros Biopharmaceutical Fund; HealthCare Ventures; Morgenthaler; and Sequel Venture Partners...

...investors in the infectious disease company included Perseus-Soros Biopharmaceutical Fund; HealthCare Ventures; Morgenthaler Ventures; and Sequel Venture Partners...

...stockholders include New Enterprise Associates (28.5%); JPMorgan (20.4%); InterWest (13%); Perseus-Soros BioPharmaceutical Fund (8.1%); and Sequel Venture Partners...